continuous subcutaneous insulin infusion

(redirected from CSII)
Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.

continuous subcutaneous insulin infusion

delivery of insulin to subcutaneous tissue by a pump using both continuous and bolus infusions.

continuous subcutaneous insulin infusion

Abbreviation: CSII
Administration of insulin under the skin continuously with an infusion pump connected to a needle inserted beneath the epidermis.
See: insulin pump
See also: infusion
References in periodicals archive ?
Patients on MDI were also trained in carbohydrate counting and the use of insulin sensitivity factors for calculating correction boluses and had access to the treating team similar to the CSII group.
1c] between baseline and the last follow-up visit in both CSII and MDI groups.
The characteristics of 326 children on CSII and 328 on MDI are shown in Table 1.
The main reasons for switching to CSII given by the patients or their caregivers were achieving better control (n=143; 43.
The numbers increased in the CSII group compared to MDI throughout the study period.
Overall, these findings suggest that families of adolescents using CSII experience a variety of problematic situations that occur across multiple contexts.
The information obtained in this study can also be used to help inform families considering CSII about the variety of difficult situations that arise across contexts (e.
Additional exploration and content analyses of the qualitative data gathered in this study could yield further rich, descriptive, and sequential accounts of problems experienced by families of youth using CSII as well as the contexts in which these problems occurred.
Although no significant demographic and disease differences were found between the study participants and nonparticipants, all patients using CSII in the diabetes clinic have already been deemed "well suited" and therefore constitute a biased sample compared with the general population of youth with T1DM.
PaQ Insulin Delivery Device is a simple three-day insulin delivery device that enables patients to experience the benefits of CSII without the complexity of daily insulin injections.